Analyst Ratings for Iovanace Biotherapeutics (IOVA)
IOVA Rating Summary
IOVA Price Target Summary
- Highest: $14.00 (Wells Fargo)
- Lowest: $4.00 (Baird)
- Average: $8.43
* Over Last 12-Mos
Overall Rating:
NEUTRAL
Rating Trend:
Avg. $ Target:
$8.43 (+68.6%)
* Over Last 12-Mos
Rating Score: 6 / 10
Percentile Rank: 63%
Avg. $ Target:
$8.43 (+68.6%)
* Over Last 12-Mos
Rating Score: 6 / 10
Percentile Rank: 63%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 2/25/2026 | Citizens » Updated 6/1/2026 |
Reni J. Benjamin | Upgrade | Market Outperform (Market Perform) |
5.00 (N/A) |
2.89 (5.00) |
73.01% | Details |
| 7/15/2025 | Goldman Sachs | Andrea Newkirk | Downgrade | Sell (Buy) |
1.00 (8.00) |
1.87 (5.00) |
167.38% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
